Skip to main content
SpringerLink
Log in

Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objective

Pediatric genitourinary rhabdomyosarcoma (RMS) accounts for 25 % of all pediatric soft tissue sarcomas. The treatment of these tumors has shifted over time from debilitating radical exenteration to organ-sparing techniques using multimodal therapy. Our review aims to summarize recent relevant literature regarding the current treatment practices of pediatric genitourinary RMS and how these practices have shifted over time.

Methods

PubMed database search was utilized to identify relevant literature from 1997 to 2015 relating to the treatment of pediatric genitourinary RMS with emphasis on organ preservation and maintaining organ function.

Results

A total of 31 articles from 1997 through 2015 were identified relating to current management concepts in pediatric genitourinary sarcomas. Relevant articles were reviewed in detail and discussed.

Conclusion

The treatment of pediatric genitourinary RMS has shifted from debilitating pelvic exenteration to a multimodal treatment approach involving surgery, chemotherapy, and radiation therapy in an effort to preserve genitourinary organs and reduce treatment morbidity. Continued research is required to improve post-treatment organ function. Further studies utilizing objective urodynamic evaluation are necessary to better characterize bladder function after treatment for RMS. Exciting recent developments in RMS research of fusion proteins that induce cell transformation and inhibit apoptosis and myogenic differentiation may result in future management changes to treatment protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rodeberg D, Anderson Jr, Arndt C et al (2011) Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children’s Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Int J Cancer 128:1232–1239

    Article  CAS  PubMed  Google Scholar 

  2. Wu H-Y, Snyder HM, Womer RB (2009) Genitourinary rhabdomyosarcoma: which treatment, how much, and when? J Pediatr Urol 5:501–506

    Article  PubMed  Google Scholar 

  3. Michalkiewicz EL, Rao BN, Gross E et al (1997) Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma. J Pediatr Surg 32:1277–1282

    Article  CAS  PubMed  Google Scholar 

  4. Ferrer FA, Isakoff M, Koyle MA (2006) Bladder/prostate rhabdomyosarcoma: past, present and future. J Urol 176:1283–1291

    Article  PubMed  Google Scholar 

  5. Martelli H, Haie-Meder C, Branchereau S et al (2009) Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. J Pediatr Surg 44:190–196

    Article  PubMed  Google Scholar 

  6. Dorr W, Beck-Bornholdt H (1999) Radiation-induced impairment of urinary bladder function in mice: fine structure of the acute response and consequences on late effects. Radiat Res 151:461–467

    Article  CAS  PubMed  Google Scholar 

  7. Walterhouse DO, Meza JL, Breneman JC et al (2011) Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children’s Oncology Group. Pediatr Blood Cancer 57:76

    Article  PubMed  PubMed Central  Google Scholar 

  8. Malempati S, Hawkins DS (2012) Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies. Hoboken 59:5–10

    Google Scholar 

  9. Gosiengfiao Y, Reichek J, Walterhouse D (2012) What is new in rhabdomyosarcoma management in children? Pediatr Drugs 14:389–400

    Google Scholar 

  10. Lin C et al (2012) Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803—a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys 82:1764–1770

    Article  PubMed  Google Scholar 

  11. Cotter SE (2011) Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 81:1367–1373

    Article  PubMed  Google Scholar 

  12. Terezakis SA, Wharam MD (2013) Radiotherapy for rhabdomyosarcoma: indications and outcome. Clin Oncol 25:27–35

    Article  CAS  Google Scholar 

  13. Heinzelmann F, Thorwarth D, Lamprecht U et al (2011) Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery. (Report). Strahlenther Onkol 187:715

    Article  PubMed  Google Scholar 

  14. Wu H-Y, Snyder HM (2004) Pediatric urologic oncology: bladder, prostate, testis. Urol Clin N Am 31:619–627

    Article  Google Scholar 

  15. Rodeberg DA, Anderson JR, Arndt CA et al (2011) Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children’s oncology group, German cooperative soft tissue sarcoma study, Italian cooperative group, and International society of pediatric oncology malignant mesenchymal tumors committee. Int J Cancer 128:1232

    Article  CAS  PubMed  Google Scholar 

  16. Arndt C, Rodeberg D, Breitfeld PP, Raney R, Ullrich F, Donaldson S (2004) Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from Intergroup Rhabdomyosarcoma Study IV. J Urol 171:2396–2403

    Article  PubMed  Google Scholar 

  17. Soler R, Macedo A, Bruschini H et al (2005) Does the less aggressive multimodal approach of treating bladder-prostate rhabdomyosarcoma preserve bladder function? J Urol 174:2343–2346

    Article  PubMed  Google Scholar 

  18. Raney B, Anderson J, Jenney M et al (2006) Late effects in 164 patients with rhabdomyosarcoma of the bladder/prostate region: a report from the international workshop. J Urol 176:2190–2195

    Article  PubMed  Google Scholar 

  19. Skapek SX, Anderson J, Barr FG et al (2013) PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children’s oncology group report. Pediatr Blood Cancer 60:1411

    Article  PubMed  PubMed Central  Google Scholar 

  20. Frederic GB, Naomi G, John H, Jaclyn AB, Giovanni R, Beverly SE (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3:113

    Article  Google Scholar 

  21. Davis R, Dcruz CM, Lovell MA, Biegel J, Barr F (1994) Fusion of PAX7 to FKHR by the variant (1,13)(P36, Q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869–2872

    CAS  PubMed  Google Scholar 

  22. Naomi G, Richard JD, William JF et al (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5:230

    Article  Google Scholar 

  23. Melcón SG, de Toledo Codina JS (2007) Molecular biology of rhabdomyosarcoma. Clin Transl Oncol 9:415–419

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Urology, Department of Urology, University of Wisconsin School of Medicine and Public Health, 3217 MFCB, 1685 Highland Ave, Madison, WI, 53705-2281, USA

    Daniel D. Shapiro & Patrick H. McKenna

  2. Division of Urology, Department of Surgery, Connecticut Children’s Medical Center, Hartford, CT, USA

    Miriam Harel & Fernando Ferrer

Authors
  1. Daniel D. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miriam Harel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando Ferrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick H. McKenna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick H. McKenna.

Ethics declarations

Conflict of interest

Daniel D. Shapiro declares that he has no conflict of interest. Miriam Harel declares that she has no conflict of interest. Fernando Ferrer declares that he has no conflict of interest. Patrick H. McKenna declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shapiro, D.D., Harel, M., Ferrer, F. et al. Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma. Int Urol Nephrol 48, 1009–1013 (2016). https://doi.org/10.1007/s11255-016-1285-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-016-1285-0

Keywords

Search

Navigation